PMID- 23312788 OWN - NLM STAT- MEDLINE DCOM- 20131125 LR - 20221207 IS - 1873-460X (Electronic) IS - 1056-8727 (Linking) VI - 27 IP - 3 DP - 2013 May-Jun TI - Comparison of annual variability in HbA1c and glycated albumin in patients with type 1 vs. type 2 diabetes mellitus. PG - 211-3 LID - S1056-8727(12)00338-8 [pii] LID - 10.1016/j.jdiacomp.2012.12.001 [doi] AB - OBJECTIVE: It has been suggested that plasma glucose (PG) levels per se and long-term variations in PG levels are associated with diabetic vascular complications. Glycated albumin (GA) reflects shorter-term glycemic control, as well as postprandial PG levels, as compared to HbA1c. In this study, we hypothesized that GA more strongly reflects long-term variations in PG levels than HbA1c, and compared the variability of HbA1c and that of GA in patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). METHODS: This study included 8 T1DM patients and 48 T2DM patients. Over a 1-year period, HbA1c and GA were measured every month and the mean values and coefficients of variation (CV) for each patient were calculated. RESULTS: In both T1DM and T2DM patients, the CV of GA was significantly higher than the CV of HbA1c. Both the CV of HbA1c and the CV of GA were significantly higher in the T1DM patients than in the T2DM patients. CONCLUSION: The annual variability in GA was greater than that in HbA1c. In addition, the annual variability in HbA1c and that in GA in the T1DM patients were greater than in the T2DM patients. Our findings suggest that GA more accurately reflects long-term variations in PG levels than HbA1c. CI - Copyright (c) 2013 Elsevier Inc. All rights reserved. FAU - Koga, Masafumi AU - Koga M AD - Department of Internal Medicine, Kawanishi City Hospital, 5-21-1 Higashi-uneno, Kawanishi 666-0195, Japan. m-koga@kawanishi-city-hospital.com FAU - Murai, Jun AU - Murai J FAU - Morita, Shinya AU - Morita S FAU - Saito, Hiroshi AU - Saito H FAU - Kasayama, Soji AU - Kasayama S LA - eng PT - Comparative Study PT - Journal Article PT - Multicenter Study DEP - 20130110 PL - United States TA - J Diabetes Complications JT - Journal of diabetes and its complications JID - 9204583 RN - 0 (Biomarkers) RN - 0 (Glycated Hemoglobin A) RN - 0 (Glycation End Products, Advanced) RN - 0 (Serum Albumin) RN - 0 (hemoglobin A1c protein, human) RN - 0 (Glycated Serum Albumin) SB - IM MH - Aged MH - Biomarkers/blood MH - Diabetes Mellitus, Type 1/*blood/complications/therapy MH - Diabetes Mellitus, Type 2/*blood/complications/therapy MH - Diabetic Angiopathies/epidemiology MH - Female MH - Glycated Hemoglobin/*analysis MH - Glycation End Products, Advanced MH - Humans MH - Hyperglycemia/*epidemiology/prevention & control MH - Japan/epidemiology MH - Male MH - Middle Aged MH - Risk Factors MH - Serum Albumin/*analysis MH - Glycated Serum Albumin EDAT- 2013/01/15 06:00 MHDA- 2013/12/16 06:00 CRDT- 2013/01/15 06:00 PHST- 2012/04/17 00:00 [received] PHST- 2012/11/08 00:00 [revised] PHST- 2012/12/04 00:00 [accepted] PHST- 2013/01/15 06:00 [entrez] PHST- 2013/01/15 06:00 [pubmed] PHST- 2013/12/16 06:00 [medline] AID - S1056-8727(12)00338-8 [pii] AID - 10.1016/j.jdiacomp.2012.12.001 [doi] PST - ppublish SO - J Diabetes Complications. 2013 May-Jun;27(3):211-3. doi: 10.1016/j.jdiacomp.2012.12.001. Epub 2013 Jan 10.